{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:56:27Z","timestamp":1787162187485,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":964,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jval.2010.10.012","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T07:39:47Z","timestamp":1299569987000},"page":"160-165","source":"Crossref","is-referenced-by-count":4,"title":["Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?"],"prefix":"10.1016","volume":"14","author":[{"given":"Katherine","family":"Gooch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Feeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Kupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen L.","family":"Pangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Revicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2010.10.012_bib1","first-page":"4","article-title":"The burden of ankylosing spondylitis","volume":"78","author":"Boonen","year":"2006","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.jval.2010.10.012_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#","article-title":"Functional disability predicts total costs in patients with ankylosing spondylitis","volume":"46","author":"Ward","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2010.10.012_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/berh.2002.0244","article-title":"Ankylosing spondylitis: what is the cost to society, and can it be reduced?","volume":"16","author":"Boonen","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib4","series-title":"Cost-Effectiveness in Health and Medicine","year":"1996"},{"key":"10.1016\/j.jval.2010.10.012_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The Health Utilities Index (HUI): concepts, measurement properties and applications","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2010.10.012_bib6","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.21913","article-title":"Efficacy and safety of adalimumab in patients with ankylosing spondylitis","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2010.10.012_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.22887","article-title":"Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study","volume":"57","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2010.10.012_bib8","first-page":"1346","article-title":"Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)","volume":"35","author":"Revicki","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.2007.087270","article-title":"Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long term results from the ATLAS trial","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jval.2010.10.012_bib10","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2790","article-title":"Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis","volume":"11","author":"van der Heijde","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jval.2010.10.012_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2010.10.012_bib12","first-page":"651","article-title":"The development of the ankylosing spondylitis quality of life questionnaire","volume":"8","author":"Reynolds","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2010.10.012_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jval.2010.10.012_bib14","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib15","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib16","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS)","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib17","series-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","article-title":"Health utilities index","author":"Feeny","year":"1996"},{"key":"10.1016\/j.jval.2010.10.012_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890109002092","article-title":"The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies","volume":"33","author":"Furlong","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.jval.2010.10.012_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","article-title":"Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system","volume":"40","author":"Feeny","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2010.10.012_bib20","first-page":"592","article-title":"The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review","volume":"35","author":"Harrison","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2010.10.012_bib21","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jval.2010.10.012_bib22","series-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.jval.2010.10.012_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/B:QURE.0000018479.52075.bf","article-title":"Is the Health Utilities Index valid in total hip arthroplasty patients?","volume":"13","author":"Blanchard","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2010.10.012_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life in clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.jval.2010.10.012_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00435966","article-title":"Measuring quality of life in the parents of children with asthma","volume":"5","author":"Juniper","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2010.10.012_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00435967","article-title":"Measuring quality of life in children with asthma","volume":"5","author":"Juniper","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2010.10.012_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2004.08.005","article-title":"A cohort study found the RAND-12 and Health Utilities Mark 3 demonstrated construct validity in high-risk primary-care patients","volume":"58","author":"Feeny","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2010.10.012_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11136-009-9457-3","article-title":"The construct validity of the Health Utilities Index Mark 3 in assessing mental health in population health surveys","volume":"18","author":"Feeny","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2010.10.012_bib29","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheum"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T18:14:58Z","timestamp":1588788898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1098301510000136"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2010.10.012","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}